{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:59:24Z","timestamp":1770958764622,"version":"3.50.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1126,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1111\/j.1365-2133.2012.11084.x","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T03:09:07Z","timestamp":1344568147000},"page":"29-35","source":"Crossref","is-referenced-by-count":16,"special_numbering":"supplement s2","title":["Assessing physicians\u2019 preferences on skin cancer treatment in Europe"],"prefix":"10.1093","volume":"167","author":[{"given":"L.","family":"Ferrandiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruiz-de-Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Trakatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Aquilina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Saksela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ranki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Proby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Magnoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pitk\u00e4nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kalokasidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Siskou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Altsitsiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Stockfleth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Moreno-Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the EPIDERM Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB1|cit1","volume-title":"Guideline on Actinic Keratoses","author":"Stockfleth","year":"2011"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2006.07692.x","article-title":"Guidelines for the management of actinic keratoses","volume":"156","author":"De Berker","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.2008.08666.x","article-title":"Guidelines for the management of basal cell carcinoma","volume":"159","author":"Telfer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2133.2006.07610.x","article-title":"Guidelines for the management of Bowen\u2019s disease: 2006 update","volume":"156","author":"Cox","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1524-4725.2009.01379.x","article-title":"Epidemiology of surgical treatment of nonmelanoma skin cancer in the head and neck in Greece","volume":"36","author":"Seretis","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/j.1524-4725.2010.01805.x","article-title":"Assessing the public\u2019s preference for surgical treatment of primary basal cell carcinoma: a discrete-choice experiment in the south of the Netherlands","volume":"36","author":"Essers","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bmj.38219.515266.AE","article-title":"Interventions for basal cell carcinoma of the skin: systematic review","volume":"329","author":"Bath-Hextall","year":"2004","journal-title":"BMJ"},{"issue":"Suppl. 3","key":"10.1111\/j.1365-2133.2012.11084.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/jdt.14.s3.3.10","article-title":"Current treatment patterns in non-melanoma skin cancer across Europe","volume":"14","author":"Schmook","year":"2003","journal-title":"J Dermatolog Treat"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2012.11084.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2012.11081.x","article-title":"Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study","volume":"167","author":"De Vries","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(08)70260-2","article-title":"Surgical excision versus Mohs\u2019 micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years\u2019 follow-up","volume":"9","author":"Mosterd","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB11|cit11","first-page":"622","article-title":"Cost analysis of Mohs micrographic surgery in high-risk facial basal cell carcinoma","volume":"101","author":"Blazquez-Sanchez","year":"2010","journal-title":"Actas Dermosifiliogr"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archderm.142.2.187","article-title":"Cost-effectiveness of Mohs micrographic surgery vs surgical excision of basal cell carcinoma of the face","volume":"142","author":"Essers","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2133.2005.06486.x","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe","volume":"152","author":"Schulze","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1524-4725.2006.32228.x","article-title":"Frequency and cost of actinic keratosis treatment","volume":"32","author":"Warino","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-0-387-78574-5_36","article-title":"Topical treatment of field cancerization","volume":"146","author":"Ulrich","year":"2009","journal-title":"Cancer Treat Res"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2012.11084.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0001-7310(09)73379-4","article-title":"Field treatment of actinic keratoses - focus on COX-2-inhibitors","volume":"100","author":"Ulrich","year":"2009","journal-title":"Actas Dermosifiliogr"},{"key":"10.1111\/j.1365-2133.2012.11084.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-3-642-59410-6_31","article-title":"New treatment modalities for basal cell carcinoma","volume":"160","author":"Stockfleth","year":"2002","journal-title":"Recent Results Cancer Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.11084.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.11084.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:56:22Z","timestamp":1676382982000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/s2\/29\/6614026"}},"subtitle":["Skin cancer treatment in Europe"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":17,"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11084.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}